5759-63-7 Purity
---
If you have any other questions or need other size, please get a quote.
Reference: [1] Synthetic Communications, 1980, vol. 10, # 1, p. 17 - 24
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 1996, vol. 6, # 18, p. 2173 - 2176
[2] Synthetic Communications, 1980, vol. 10, # 1, p. 17 - 24
[3] Chemical and pharmaceutical bulletin, 1987, vol. 35, # 5, p. 1953 - 1968
Reference: [1] Journal of Medicinal Chemistry, 1991, vol. 34, # 8, p. 2525 - 2547
Reference: [1]Perchonock; Uzinskas; McCarthy; Erhard; Gleason; Wasserman; Muccitelli; DeVan; Tucker; Vickery
[Journal of Medicinal Chemistry, 1986, vol. 29, # 8, p. 1442 - 1452]
[2]Current Patent Assignee: GLAXOSMITHKLINE PLC - US5135938, 1992, A
Current Patent Assignee: GLAXOSMITHKLINE PLC - US5143931, 1992, A
Reference: [1]Nate; Sekine; Honma; Nakai; Wada; Takeda; Yabana; Nagao
[Chemical and pharmaceutical bulletin, 1987, vol. 35, # 5, p. 1953 - 1968]
[2]Current Patent Assignee: ELI LILLY & CO - US5028629, 1991, A
Reference: [1]Perchonock; McCarthy; Erhard; Gleason; Wasserman; Muccitelli; DeVan; Tucker; Vickery; Kirchner
[Journal of Medicinal Chemistry, 1985, vol. 28, # 9, p. 1145 - 1147]
* For details of the synthesis route, please refer to the original source to ensure accuracy.